Holen Sie sich die Stockscreener-App
12.32
0.00%
0.00
Handel nachbörslich:
12.28
-0.04
-0.32%
Schlusskurs vom Vortag:
$12.32
Offen:
$12.19
24-Stunden-Volumen:
1.99M
Relative Volume:
0.85
Marktkapitalisierung:
$2.14B
Einnahmen:
$61.10M
Nettoeinkommen (Verlust:
$-138.36M
KGV:
-9.1259
EPS:
-1.35
Netto-Cashflow:
$-90.59M
1W Leistung:
+3.01%
1M Leistung:
+0.90%
6M Leistung:
+77.52%
1J Leistung:
+36.28%
1-Tages-Spanne:
$12.19
$12.46
1-Wochen-Bereich:
$11.82
$12.49
52-Wochen-Spanne:
$5.80
$12.91
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Firmenname
Ocular Therapeutix Inc
Sektor
Branche
Telefon
781-357-4000
Adresse
15 CROSBY DRIVE, BEDFORD, MA
Vergleichen Sie OCUL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
12.32 | 2.14B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Eingeleitet | William Blair | Outperform |
| 2025-03-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-03-11 | Eingeleitet | Needham | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-20 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-02-09 | Eingeleitet | BofA Securities | Buy |
| 2023-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-10 | Fortgesetzt | Berenberg | Buy |
| 2021-08-10 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-11-13 | Bestätigt | Raymond James | Strong Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | Herabstufung | Cowen | Outperform → Market Perform |
| 2019-05-21 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-11-15 | Eingeleitet | Raymond James | Strong Buy |
| 2018-09-07 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2017-07-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-07-12 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-06-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-08-11 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2016-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Ocular Therapeutix Executives Engage in Stock Transactions - TradingView
Statistical indicators supporting Ocular Therapeutix Inc.’s strengthJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - Newser
Ocular Therapeutix Inc. stock trend outlook and recovery path2025 Price Momentum & Low Risk Entry Point Guides - Newser
Ocular Therapeutix Inc. stock retracement – recovery analysis2025 Analyst Calls & Safe Entry Point Identification - Newser
How hedge fund analytics apply to Ocular Therapeutix Inc. stockDividend Hike & Real-Time Stock Entry Alerts - Newser
Has Ocular Therapeutix Inc. found a price floorMarket Trend Report & Capital Efficiency Focused Strategies - Newser
Is Ocular Therapeutix Inc. stock poised for growthBull Run & Low Drawdown Trading Strategies - Newser
Does Ocular Therapeutix Inc. fit your quant trading modelGap Down & Detailed Earnings Play Alerts - Newser
Retina Treatment Innovation: Ocular Therapeutix to Showcase OTX-TKI Data at 5 Major Medical Conferences - Stock Titan
News impact scoring models applied to Ocular Therapeutix Inc.2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Ocular Therapeutix Drops 10.71% on Earnings Miss - AInvest
Visual trend scoring systems applied to Ocular Therapeutix Inc.Gap Down & Expert Approved Trade Ideas - Newser
Historical volatility pattern of Ocular Therapeutix Inc. visualizedShort Setup & Weekly Chart Analysis and Guides - Newser
Is it time to cut losses on Ocular Therapeutix Inc.Earnings Beat & Technical Buy Zone Confirmation - Newser
Best data tools to analyze Ocular Therapeutix Inc. stockJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Chart based analysis of Ocular Therapeutix Inc. trendsJuly 2025 Highlights & AI Forecast Swing Trade Picks - Newser
What high frequency data says about Ocular Therapeutix Inc.July 2025 Final Week & Capital Protection Trading Alerts - Newser
Quantitative breakdown of Ocular Therapeutix Inc. recent moveShare Buyback & Consistent Return Strategy Ideas - Newser
Ocular Therapeutix Inc. Rebound Backed by Sentiment Shift2025 Fundamental Recap & Free Accurate Trade Setup Notifications - classian.co.kr
What are Ocular Therapeutix Inc.’s earnings expectationsJuly 2025 Retail & AI Enhanced Trading Signals - theviewers.co.kr
Using Bollinger Bands to evaluate Ocular Therapeutix Inc.July 2025 Breakouts & Real-Time Volume Analysis - Newser
Is There Enough Volume to Lift Ocular Therapeutix Inc.Market Trend Summary & Precise Buy Zone Identification - 더경남뉴스
Backtesting results for Ocular Therapeutix Inc. trading strategiesWeekly Trade Analysis & High Accuracy Investment Entry Signals - Newser
Ocular Therapeutix Inc. Shows Support at Fibonacci LevelJuly 2025 Outlook & Weekly High Conviction Ideas - newsyoung.net
Ocular Therapeutix Inc. Stock Poised for Technical ComebackJuly 2025 Closing Moves & Weekly Top Stock Performers List - mustnews.co.kr
Is Ocular Therapeutix Inc. stock bottoming outTrade Risk Report & Community Consensus Stock Picks - Newser
Can swing trading help recover from Ocular Therapeutix Inc. lossesStock Surge & AI Driven Price Predictions - Newser
Has Ocular Therapeutix Inc. Stock Ever Crashed Historical Volatility ReviewMarket Activity Summary & Fast Moving Market Watchlists - Newser
What makes Ocular Therapeutix Inc. stock price move sharply2025 Price Momentum & Breakout Confirmation Alerts - Newser
Using data filters to optimize entry into Ocular Therapeutix Inc.Portfolio Return Report & Low Drawdown Trading Strategies - Newser
Ocular gets FDA agreement for registrational trial of Axpaxl - MSN
Quant Strategy Flags Ocular Therapeutix Inc. for EntryJuly 2025 Earnings & Community Consensus Picks - newsyoung.net
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2025 Earnings Call Transcript - MSN
What earnings revisions data tells us about Ocular Therapeutix Inc.July 2025 Drop Watch & Community Shared Stock Ideas - Newser
Momentum divergence signals in Ocular Therapeutix Inc. chartPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Ocular Therapeutix receives FDA agreement under SPA for registrational trial of AXPAXLI in NPDR - Eyes On Eyecare
FDA agrees to SPA for Ocular Therapeutix NPDR registrational trial - Eyes On Eyecare
Ocular Therapeutix at H.C. Wainwright: Strategic Moves in Eye Care By Investing.com - Investing.com Canada
Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):